Results from Western blot analysis showed that the protein expression of BCL-XL was significantly increased in PBMCs of patients with T1DM compared to healthy individuals (Figure 1D), suggesting the low expression of miR-296-5p and high expression of Bcl-xl in PBMCs of patients with T1DM. This evidence concerns the gene BCL2L1 and type 1 diabetes mellitus.